A behavioral weight-loss intervention in persons with serious mental illness

New England Journal of Medicine

Volumn 368, Issue 17, 2013, Pages 1594-1602

  Daumit, Gail L ^a,b,c   Dickerson, Faith B ^e   Wang, Nae Yuh ^a,b,c   Dalcin, Arlene ^b   Jerome, Gerald J ^b,f   Anderson, Cheryl A M ^h   Young, Deborah R ⁱ   Frick, Kevin D ^c   Yu, Airong ^b   Gennusa III, Joseph V ^b   Oefinger, Meghan ^b   Crum, Rosa M ^a,b,c   Charleston, Jeanne ^a,b   Casagrande, Sarah S ^g   Guallar, Eliseo ^a,c,j   Goldberg, Richard W ^d   Campbell, Leslie M ^b   Appel, Lawrence J ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e SHEPPARD PRATT HEALTH SYSTEM   (United States)

^f TOWSON UNIVERSITY   (United States)

^g SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ KAISER PERMANENTE   (United States)

^j CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AEROBIC EXERCISE; ARTICLE; BEHAVIOR THERAPY; BIPOLAR DISORDER; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MORTALITY; OBESITY; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; THERAPY EFFECT; TREATMENT OUTCOME; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 84876531583     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1214530     Document Type: Article

References (54)

1. Colton CP, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006;3:A42.
2. Daumit GL, Anthony CB, Ford DE, et al. Pattern of mortality in a sample of Maryland residents with severe mental illness. Psychiatry Res 2010;176:242-5.
3. Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care 2011;49:599-604.
4. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123-31. (Pubitemid 47529346)
5. Allison DB, Newcomer JW, Dunn AL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med 2009;36:341-50.
6. Coodin S. Body mass index in persons with schizophrenia. Can J Psychiatry 2001;46:549-55. (Pubitemid 32861422)
7. Daumit GL, Clark JM, Steinwachs DM, Graham CM, Lehman A, Ford DE. Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis 2003;191:799-805. (Pubitemid 37549666)
8. Dickerson FB, Brown CH, Kreyenbuhl JA, et al. Obesity among individuals with serious mental illness. Acta Psychiatr Scand 2006;113:306-13.
9. McElroy SL. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207-13. (Pubitemid 34407079)
10. Bresee LC, Majumdar SR, Patten SB, Johnson JA. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res 2010;117:75-82.
11. Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med 2006;21:1133-7. (Pubitemid 44506864)
12. Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006;68:684-91. (Pubitemid 44454636)
13. Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatry 2004;161:2317-9. (Pubitemid 39587302)
14. McEvoy JP, Meyer JM, Goff DC, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005;80:19-32. (Pubitemid 41587460)
15. McGinty EE, Zhang Y, Guallar E, et al. Cancer incidence in a sample of Maryland residents with serious mental illness. Psychiatr Serv 2012;63:714-7.
16. Daumit GL, Goldberg RW, Anthony C, et al. Physical activity patterns in adults with severe mental illness. J Nerv Ment Dis 2005;193:641-6. (Pubitemid 41475857)
17. Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The dietary patterns of patients with schizophrenia: a systematic review. J Psychiatr Res 2013;47:197-207.
18. Jerome GJ, Young DR, Dalcin A, et al. Physical activity levels of persons with mental illness attending psychiatric rehabilitation programs. Schizophr Res 2009;108:252-7.
19. Depression Guideline Panel. Depression in primary care. Vol. 2. Rockville, MD: Agency for Health Care Policy and Research, 1993. (AHCPR publication no. 93-0551.)
20. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-96. (Pubitemid 29517559)
21. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-23. [Erratum, N Engl J Med 2010;363:1092-3.] (Pubitemid 41345943)
22. Macritchie KAN, Geddes JR, Scott J, Haslam DRS, Goodwin GM. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2001;3:CD003196.
23. Stamler R, Stamler J, Gosch FC, et al. Primary prevention of hypertension by nutritional-hygienic means: final report of a randomized, controlled trial. JAMA 1989;262:1801-7. [Erratum, JAMA 1989;262:3132.] (Pubitemid 19239467)
24. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001;134:1-11. (Pubitemid 32037337)
25. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50. (Pubitemid 32378388)
26. Mueser KT, McGurk SR. Schizophrenia. Lancet 2004;363:2063-72. (Pubitemid 38781110)
27. Agerbo E, Byrne M, Eaton WW, Mortensen PB. Marital and labor market status in the long run in schizophrenia. Arch Gen Psychiatry 2004;61:28-33. (Pubitemid 38044638)
28. Hudson CG. Socioeconomic status and mental illness: tests of the social causation and selection hypotheses. Am J Orthopsychiatry 2005;75:3-18. (Pubitemid 40261725)
29. Hinshaw S. The mark of shame: stigma of mental illness and an agenda for change. New York: Oxford University Press, 2007.
30. Thornicroft G, Brohan E, Rose D, Sartorius N, Leese M. Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey. Lancet 2009;373:408-15.
31. Appel LJ, Clark JM, Yeh HC, et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med 2011;365:1959-68.
32. Elmer PJ, Obarzanek E, Vollmer WM, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006;144:485-95. (Pubitemid 46780671)
33. Hollis JF, Gullion CM, Stevens VJ, et al. Weight loss during the intensive intervention phase of the Weight Loss Maintenance trial. Am J Prev Med 2008;35:118-26. (Pubitemid 351927268)
34. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009;360:859-73.
35. Wadden TA, Volger S, Sarwer DB, et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 2011;365:1969-79.
36. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE). JAMA 1998;279:839-46. (Pubitemid 28185548)
37. Cabassa LJ, Ezell JM, Lewis-Fernandez R. Lifestyle interventions for adults with serious mental illness: a systematic literature review. Psychiatr Serv 2010;61:774-82.
38. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 2007;1:CD005148.
39. Casagrande SS, Jerome GJ, Dalcin AT, et al. Randomized Trial of Achieving Healthy Lifestyles in Psychiatric Rehabilitation: the ACHIEVE trial. BMC Psychiatry 2010;10:108.
40. Bandura A, ed. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, NJ: Prentice-Hall, 1986.
41. Heinssen RK. The cognitive exoskeleton: environmental interventions in cognitive rehabilitation. In: Corrigan PW, Yudofsky SC, eds. Cognitive rehabilitation for neuropsychiatric disorders. Washington, DC: American Psychiatric Press, 1996:395-423.
42. Mueser KT, Corrigan PW, Hilton DW, et al. Illness management and recovery: a review of the research. Psychiatr Serv 2002;53:1272-84.
43. Green MF, Nuechterlein KH. Should schizophrenia be treated as a neurocognitive disorder? Schizophr Bull 1999;25:309-19. (Pubitemid 29272507)
44. Velligan DI, Bow-Thomas CC, Huntzinger C, et al. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. Am J Psychiatry 2000;157:1317-23. (Pubitemid 30659817)
45. American Heart Association, National Heart, Lung, and Blood Institute. Exercise and your heart: a guide to physical activity. Bethesda, MD: National Institutes of Health, 1993.
46. Eisen SV, Normand SL, Belanger AJ, Spiro A III, Esch D. The Revised Behavior and Symptom Identification Scale (BASISR): reliability and validity. Med Care 2004;42:1230-41. (Pubitemid 39627300)
47. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977;106:203-14. (Pubitemid 8190169)
48. Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status. Psychiatry Res 2004;129:45-53. (Pubitemid 39574436)
49. Foster GD, Wyatt HR, Hill JO, et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med 2010;153:147-57.
50. Bartels SJ, Desilets R. Health promotion programs for people with serious mental illness (prepared by the Dartmouth Health Promotions Research Team). Washington, DC: SAMHSA-HRSA Center for Integrated Health Solutions, January 2012.
51. McKibbin CL, Patterson TL, Norman G, et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006;86:36-44. (Pubitemid 44234047)
52. Verhaeghe N, De Maeseneer J, Maes L, Van Heeringen C, Annemans L. Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Int J Behav Nutr Phys Act 2011;8:28.
53. Wu MK, Wang CK, Bai YM, Huang CY, Lee SD. Outcomes of obese, clozapinetreated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv 2007;58:544-50.
54. Wu RR, Zhao JP, Jin H, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008;299:185-93.